Compounds > 9-hydroxy-10,12-octadecadienoic acid

9-hydroxy-10,12-octadecadienoic acid and Acute Relapsing Multiple Sclerosis

9-hydroxy-10,12-octadecadienoic acid has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ernerudh, J; Ghafouri, B; Ghafouri, N; Gouveia-Figueira, S; Håkansson, I; Nording, M; Vrethem, M1

Other Studies

1 other study(ies) available for 9-hydroxy-10,12-octadecadienoic acid and Acute Relapsing Multiple Sclerosis

ArticleYear
Oxylipins in cerebrospinal fluid in clinically isolated syndrome and relapsing remitting multiple sclerosis.
    Prostaglandins & other lipid mediators, 2018, Volume: 138

    Topics: Adult; Biomarkers; Chromatography, Liquid; Demyelinating Diseases; Female; Humans; Linoleic Acids; Linoleic Acids, Conjugated; Longitudinal Studies; Male; Multiple Sclerosis, Relapsing-Remitting; Oxylipins; Prospective Studies; Tandem Mass Spectrometry; Young Adult

2018